Caplight Directory>Companies>Amaroq Therapeutics-preview>Amaroqtx


Amaroq Therapeutics

Amaroq Therapeutics

Private
DunedinHealthcare & Life Scienceshttps://www.amaroqtx.com/

Last Round

Seed

Jul 8, 2021

Total Funding Raised

$9.7M

Momentum Score

25 /100

Company Overview

Amaroq Therapeutics is a biotechnology company that develops cancer therapeutics targeting long non-coding RNA.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Government Contracts

AI Layer

Application

Keywords

lncRNA therapeuticslong non-coding RNAlncRNAAI drug discoverydrug discovery platformprecision oncologyRNA therapeuticsfirst-in-class therapiesgenomic dark mattertarget identificationcomputational genomicscancer therapeuticspharmaceutical partnerships

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Amaroq Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Amaroq Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedJul 8, 2021
View all Funding Rounds

Amaroq Therapeutics Investors

Notable investors and investment history

InvestorRounds
Otago Innovation LtdSeed
NZ Innovation Booster FundSeed
Cure Kids VenturesSeed
Brandon BioCatalystSeed
Brandon CapitalSeed
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 29, 2024

    Monthly visitors increased 45% MoM.

  • Jul 8, 2021

    $9.7M round led by Brandon Capital

View all signals

Amaroq Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Amaroq Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Amaroq Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersDunedin
Employee Range7
Year Founded2021
Last FundingJul 8, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.